Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tatebe, Ken
GESTALT, NCT05342883: GammaTile and Stupp in Newly Diagnosed GBM	Recruiting	4	61	US	Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)	GT Medical Technologies, Inc.	Glioblastoma	07/27	12/27
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study)	Recruiting	3	180	US	Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy	GT Medical Technologies, Inc.	Brain Metastases	12/25	12/27
ESR1814205, NCT04441138: Chemoradiation Followed by Durvalumab in Poor Risk And/or Elderly Patients with Stage III NSCLC	Suspended	2	30	US	Durvalumab, MEDI4736, imfinzi	Rush University Medical Center, AstraZeneca	Stage III Non-small-cell Lung Cancer	10/26	10/28